innovent glp-1 Biologics LifeVantage MindBody GLP-1 System, Natural

Health Outcomes: There was no reduction in obesity-related medical events for GLP-1 users versus controls

Comparative effectiveness of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylureas on risk of major adverse cardiovascular events: emulation of a randomised target trial using electronic health records

Benefits of weight loss of 10% or more in patients with overweight or obesity: A review

So just to clarify, so how it works is that it, it helps to regulate insulin levels in the body, right

Scot Roberts, PhD, Chief Scientific Officer Number Of Employees: ~57 Stage: Publicly traded Financial Snapshot: The companys market cap as of July 2026 was $548 million

Theyre responding, which is better than silence, but theyre not engaging with individual feedback in a meaningful way